3 completed, 3 recruiting. 2 Phase 3, 1 Early Phase 1, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Early Phase 1 | 1 | Recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Latanoprost (0.005%): new trials by email Literature Review of Latanoprost (0.005%) trials Research Report on Latanoprost (0.005%)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects Rocklatan (Netarsudil 0.02%/ latanoprost 0.005), Latanoprost (0.005%) - Ocular Hypertension, Suspect Glaucoma | Phase 4 | Recruiting | University of Maryland, Baltimore | 50 | 2026-07-02 | 2026-07-02 |
| Optic Nerve Head Strain in Non-glaucoma Subjects Latanoprost (0.005%) - Glaucoma | Early Phase 1 | Recruiting | Johns Hopkins University | 30 | 2026-06-24 | 2026-07-13 |
| Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension QLS-111-FDC, Latanoprost (0.005%) - OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension | Phase 2 / Phase 3 | Completed | Qlaris Bio, Inc. | 64 | 2026-03-18 | 2026-07-29 |
| A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital Selective laser trabeculoplasty, Latanoprost (0.005%) - Primary Open Angle Glaucoma or Ocular Hypertension | Not applicable | Recruiting | Lagos State Health Service Commission | 138 | 2025-10-15 | 2025-12-30 |
| Effect of Latanoprost on Optic Nerve Perfusion Latanoprost (0.005%) - Treatment Outcome | Phase 1 | Completed | Zagazig University | 46 | 2024-06-24 | 2024-10-08 |
| A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma Travoprost (0.004%), Latanoprost (0.005%) - Glaucoma, Angle-Closure, Ocular Hypertension | Phase 3 | Completed | Alcon Research | 2000-01-01 | 2008-08-05 |
Ocular Hypertension (4) · Glaucoma (3) · Glaucoma, Open-Angle (3) · Glaucoma, Angle-Closure (1)
Alcon Research (1) · Johns Hopkins University (1) · Lagos State Health Service Commission (1) · Qlaris Bio, Inc. (1) · University of Maryland, Baltimore (1) · Zagazig University (1)
United States (4) · Australia (1) · Egypt (1) · Nigeria (1)
Barbara M Wirostko, MD (1) · Harry Quigley, MD (1) · Osamah Saeedi, MD (1) · Prof B. Adekoya, FWACS, MD (1)
R01EY036042 (1)